To test the accuracy of dynamic MRI with T1 mapping in patients with CD and compare this with know parameters such as CDEIS, CRP and CDAI.
ID
Bron
Verkorte titel
Aandoening
Crohn's disease, ziekte van Crohn
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The main study parameter will be the accuracy of detecting disease activity and efficacy of DCE MRI with T1 mapping at MR in patients with proven Crohn’s disease as compared to ileocolonoscopy with histopathology.
Achtergrond van het onderzoek
Crohn’s disease (CD) is a transmural inflammatory bowel disease. Grading of severity of disease is important to be able to optimally determine treatment strategy and response to treatment. Abdominal MR-imaging using luminal and intravenous contrast medium combines transmural and extra-intestinal evaluation and can accurately show presence of disease.
The marked increase in signal intensity of inflammatory on contrast-enhanced fat saturated T1-weighted sequences can be seen due to increased tissue perfusion and vascular permeability. Analysis of the time-dependent changes of signal intensity after administration of contrast medium by DCE-MRI can add valuable information about disease activity in Crohn’s disease as the kinetic of the signal variation reflects the status of tissue microcirculation.
Hypothetically, calculation of the absolute T1-values in tissue before and after intravenous injection of Gadolinium would provide objective measurements of the Gadolinium-uptake. This so-called T1-mapping in abdominal MRI could indeed be used to determine activity of disease in an objective, quantifiable, reproducible manner and could be a valuable tool to the present imperfect disease scores such as CDAI (Crohn’s Disease Activity Index), CDEIS and CRP.
Objective:
To test the accuracy of dynamic MRI with T1 mapping in patients with CD and compare this with know parameters such as CDEIS, CRP and CDAI.
Study design:
A prospective observational feasibility study. Patients will undergo the clinically planned ileocolonoscopy, a MRI scan, and fill out the PDAI and a standardized questionnaire to score the burden of both tests.
Study population:
Thirty patients with proven Crohn’s disease (by endoscopy and/or histopathology) who are scheduled to undergo ileocolonoscopy as part of their clinical follow-up will be included.
Doel van het onderzoek
To test the accuracy of dynamic MRI with T1 mapping in patients with CD and compare this with know parameters such as CDEIS, CRP and CDAI.
Onderzoeksopzet
Patients will undergo the ileocolonoscopy and the MRI will be planned before or after.
Onderzoeksproduct en/of interventie
Longer MRI scan due to extra dynamic sequence.
Publiek
M.L.W. Ziech
Meibergdreef 9
Amsterdam 1105 AZ
The Netherlands
+31 (0)20 5663740
m.l.ziech@amc.uva.nl
Wetenschappelijk
M.L.W. Ziech
Meibergdreef 9
Amsterdam 1105 AZ
The Netherlands
+31 (0)20 5663740
m.l.ziech@amc.uva.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
1. Proven Crohn’s disease (by endoscopy or histopathology);
2. Scheduled to undergo an ileocolonoscopy as part of their clinical follow-up;
3. Scheduled to undergo a MRI.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Under 18 years of age;
2. General contraindications to MRI (claustrophobia, pregnancy, renal insufficiency, pacemakers).
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL2083 |
NTR-old | NTR2200 |
Ander register | MEC AMC : 08/139 |
ISRCTN | ISRCTN wordt niet meer aangevraagd. |